Welcome to our dedicated page for Keen Vision Acquisition SEC filings (Ticker: KVAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Keen Vision Acquisition Corporation filings document the formal disclosure record of a British Virgin Islands SPAC and emerging growth company. The filings cover Nasdaq-listed ordinary shares, warrants and units; material-event reports; sponsor financing through promissory notes; and trust-account arrangements used to extend the period available to complete a business combination.
KVAC's regulatory disclosures also address amendments to the Investment Management Trust Agreement, shareholder approvals for extension mechanics, capital-structure terms, security-structure disclosures and governance matters tied to its blank-check company structure.
Mizuho Financial Group, Inc. reports beneficial ownership of 295,218 common shares of Keen Vision Acquisition Corp., representing 5.4% of the class as of 03/31/2026. The filing states the shares are directly held by Mizuho Securities USA LLC, and Mizuho Bank, Mizuho Americas and the parent Mizuho Financial Group, Inc. may be deemed indirect beneficial owners. The form is signed by Takahiro Katsura on 05/14/2026.
Keen Vision Acquisition Corporation filed its quarterly report for the three months ended March 31, 2026, showing it remains a pre‑revenue SPAC focused on completing a business combination. The company reported net income of $92,087, driven mainly by $324,931 of dividend income on funds held in its trust account, offset by $232,844 of formation and operating costs.
Following large shareholder redemptions, cash and investments in the trust account fell to $13,153,709 from $57,003,115 at December 31, 2025. The company recorded a working capital deficit of $4,373,486 and total liabilities of $7,467,809, including $2,788,022 of extension promissory notes and $1,582,880 due to a related party. As of May 6, 2026, 5,506,521 ordinary shares were issued and outstanding, of which 1,090,446 were subject to possible redemption as of March 31, 2026.
The report describes multiple trust agreement amendments and extension loans from the sponsor to push the deadline to complete a business combination to July 27, 2026. Management discloses that these factors, together with the company’s limited cash outside the trust account, raise substantial doubt about its ability to continue as a going concern if it does not close a business combination by that date.
Keen Vision Acquisition Corporation entered into a financing arrangement with its sponsor to extend the time it has to complete a business combination.
On April 21, 2026, the company issued an unsecured promissory note for $120,000 to KVC Sponsor LLC. The sponsor deposited the same amount into the company’s trust account, allowing the business combination deadline to be extended. The note bears no interest and becomes due at the closing of a business combination. The holder may convert the note into units identical to the IPO units at $10.00 per unit. By depositing $120,000 into the trust account on April 27, 2026, the company extended its business combination period to July 27, 2026.
Keen Vision Acquisition Corporation reported that it amended its binding letter of intent with Medera Inc. and its subsidiary Novoheart Group Limited. The amendment moves the target date to sign a new replacement merger agreement from April 10, 2026 to April 30, 2026.
The prior merger agreement dated September 3, 2024 had already been terminated and replaced by this letter of intent. The parties continue to use their best efforts to finalize and execute the replacement merger agreement by the new deadline.
Keen Vision Acquisition Corporation entered into a binding letter of intent with Medera Inc. and its subsidiary Novoheart Group Limited (NVH) to negotiate a replacement merger agreement. The new deal would combine NVH, a pre-clinical human disease modeling and drug discovery business, with Keen Vision, which would remain Nasdaq-listed.
The LOI sets NVH’s enterprise valuation at US$100,000,000 and requires the surviving company to have at least US$10,000,000 of available cash at closing after expenses and NVH-related debt. Cash expenses paid at closing are capped at US$700,000 for Keen Vision and US$1,300,000 for NVH, with liquidity coming from the trust account after redemptions, any PIPE financing, and NVH’s cash.
The parties aim to sign the replacement merger agreement by April 10, 2026, with closing conditions largely mirroring a prior merger agreement that has now been terminated under a mutual release. The deal must close within nine months of the LOI, and any PIPE fundraising must also be completed within nine months of signing.
Karpus Management, Inc. filed an amended Schedule 13G reporting its beneficial ownership of 294,134 common shares of Keen Vision Acquisition Corp., representing 3.18% of the class. The shares are owned by accounts managed by Karpus, a New York-based registered investment adviser.
Karpus states the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Keen Vision. Karpus has sole voting and dispositive power over these shares and reports ownership of five percent or less of the class.
Keen Vision Acquisition Corporation updated investors on its efforts to extend the time available to complete a business combination. Shareholders approved an amendment to the company’s Investment Management Trust Agreement and its memorandum and articles of association, allowing up to two additional three‑month extensions of the business combination deadline from January 27, 2026 to July 27, 2026, in each case by depositing $120,000 into the trust account.
To fund the initial extension, the sponsor provided $120,000 via an unsecured promissory note that bears no interest, matures at the closing of a business combination, and can be converted into units at $10.00 per unit. In connection with the annual meeting vote, 3,781,900 ordinary shares were tendered for redemption, and the company has deposited the initial $120,000 to extend the deadline to April 27, 2026. Shareholders also re‑elected five directors and ratified Adeptus Partners, LLC as auditor.
Keen Vision Acquisition Corporation entered into a new funding arrangement with its sponsor to gain more time to complete a merger. On November 18, 2025, the company issued an unsecured promissory note for $144,670.38 to KVC Sponsor LLC. In return, the sponsor deposited the same amount into the company’s trust account to extend the deadline for completing a business combination.
The note carries no interest and becomes due when Keen Vision closes a business combination. The sponsor may also choose to convert the note into units identical to those sold in the IPO at a price of $10.00 per unit, which ties repayment terms directly to the company’s eventual merger outcome.
Keen Vision Acquisition Corporation issued an unsecured promissory note for $144,670.38 to its sponsor in exchange for a trust deposit to extend the time to complete a business combination. The note bears no interest and matures upon the closing of a business combination. The holder may convert the note into units identical to the IPO units at $10.00 per unit.
The company extended its business combination period to November 27, 2025 after depositing $144,670.38 into the trust account on October 24, 2025. Listed securities include units (KVACU), ordinary shares (KVAC), and warrants (KVACW) with a stated exercise price of $11.50 per share.
Keen Vision Acquisition Corp. has a group of related reporting persons led by Wolverine Asset Management LLC that together hold 297,589 Ordinary Shares, representing 3.22% of the outstanding class. The stake is reported as shared voting and dispositive power only, with no sole voting or sole dispositive authority. The ownership percentage was calculated against 9,238,421 Ordinary Shares outstanding.
The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The holders include an investment manager, its parent entities, and two individuals who may be deemed to control the general partner; each is reported with the same 3.22% beneficial ownership and shared power over the shares.